Deferasirox and Hydramine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Deferasirox (deferasirox) and Hydramine (diphenhydramine hydrochloride). Common drug interactions include constipation among females and sepsis among males.
The phase IV clinical study analyzes what interactions people have when they take Deferasirox and Hydramine. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.
What is Deferasirox?
Deferasirox has active ingredients of deferasirox. eHealthMe is studying from 2,641 Deferasirox users. Check the latest studies of Deferasirox.
What is Hydramine?
Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.
32 people who take Deferasirox and Hydramine together, and have interactions are studied.

What are the common drug interactions of Deferasirox and Hydramine, by gender? *:
female:
- Constipation
- Pneumonia
- Arthralgia (joint pain)
- Cerebral haemorrhage (bleeding within the brain)
- Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
- Hospitalisation
- Periorbital haematoma (collection of blood around the eyes)
- Death
- Adenovirus infection
- Adverse drug reaction
male:
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Arthralgia (joint pain)
- Platelet count decreased
- Pyrexia (fever)
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Blast crisis in myelogenous leukaemia
- Constipation
- General physical condition
- Fall
- Head injury
What are the common drug interactions of Deferasirox and Hydramine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Adenovirus infection
30-39:
- Adverse drug reaction
- Anaemia (lack of blood)
- Headache (pain in head)
- Loss of consciousness
- Nausea (feeling of having an urge to vomit)
- Pain
- Pneumonia
- Throat irritation
- Vomiting
40-49:
- Hospitalisation
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood bilirubin increased
- Blood glucose increased
- Blood lactate dehydrogenase increased
- Epigastric discomfort
- Haematocrit decreased
- Haemoglobin decreased
- Haptoglobin decreased
50-59:
- Arthralgia (joint pain)
- Cerebral haemorrhage (bleeding within the brain)
- Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
- Periorbital haematoma (collection of blood around the eyes)
- Pneumonia
- Constipation
- Death
- Pyrexia (fever)
- Blast crisis in myelogenous leukaemia
- General physical condition
60+:
- Lung infection
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Chest pain
- Constipation
- Delirium (wild excitement)
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
- Dyspnoea (difficult or laboured respiration)
- Febrile neutropenia (fever with reduced white blood cells)
- Graft versus host disease in intestine (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body and damages intestinal mucosal membrane)
What are the existing conditions these people have? *
- Constipation: 8 people, 25.00%
- Iron Overload: 6 people, 18.75%
- Aplastic Anemia: 6 people, 18.75%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 15.62%
- Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 4 people, 12.50%
- Haemochromatosis (body to absorb more iron than usual from food): 4 people, 12.50%
- Pain: 3 people, 9.38%
- High Blood Pressure: 3 people, 9.38%
- Enlarged Prostate: 3 people, 9.38%
- Diarrhea: 3 people, 9.38%
* Approximation only. Some reports may have incomplete information.
Do you take Deferasirox and Hydramine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Deferasirox (2,641 reports)
- Hydramine (114,900 reports)
Browse all drug interactions of Deferasirox and Hydramine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Deferasirox:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Hydramine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Deferasirox and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hydramine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on deferasirox and diphenhydramine hydrochloride (the active ingredients of Deferasirox and Hydramine, respectively), and Deferasirox and Hydramine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tricor cause Fibula Fracture? - 8 seconds ago
- Drug interactions of Lactulose and Maxipime - 8 seconds ago
- Drug interactions of Celecoxib and Prilosec Otc - 20 seconds ago
- Drug interactions of Ambien Cr and Temazepam - 30 seconds ago
- Drug interactions of Benzonatate and Orphenadrine Citrate - 30 seconds ago
- Drug interactions of Benzonatate and Ivermectin - 36 seconds ago
- Could Altace cause Heart Disease Aggravated? - 42 seconds ago
- Could Creatine cause Acute Kidney Failure? - 45 seconds ago
- Could Fluoxetine Hydrochloride cause Psychomotor Hyperactivity? - 54 seconds ago
- Could Zocor cause Vitamin B12 Deficiency? - a minute ago